Related Experiment Videos
What is new in Tuberculosis?
Ye Myat1, Maddalena Cerrone2, Onn Min Kon1
1National Heart and Lung Institute, Imperial College London, London, UK; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.
Clinical Medicine (London, England)
|August 10, 2026
Summary
Tuberculosis (TB) is a growing global health threat, with increasing rates in the UK. This review highlights recent advances in TB diagnosis and treatment, crucial for effective clinical management and public health.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Tuberculosis (TB) remains a leading global infectious killer, with an estimated 10.7 million cases in 2024.
- UK TB rates have shown an upward trend in recent years, necessitating increased vigilance.
- Extrapulmonary TB presentations are common, underscoring the need for broad clinical awareness.
Purpose of the Study:
- To provide an overview of TB epidemiology, clinical features, diagnosis, and management.
- To focus on recent advancements in TB diagnostics and therapeutics.
- To highlight the relevance of these advances for UK clinical practice.
Main Methods:
- Review of current literature on TB epidemiology, diagnosis, and treatment.
- Emphasis on advancements in diagnostic technologies like PCR and Whole Genome Sequencing (WGS).
- Discussion of evolving treatment strategies for latent, active, and multidrug-resistant TB.
Main Results:
- Rapid PCR is standard for timely TB case identification.
- WGS is routinely used for drug resistance detection, transmission tracking, and public health.
- Shorter, more effective treatment regimens are now available for various TB forms.
Conclusions:
- Recent diagnostic and therapeutic advances are transforming TB clinical practice.
- Early recognition and control of TB are essential, especially with complex presentations.
- Continued integration of new tools and strategies is vital for combating TB in the UK.